Impact of Operability and Total Metastatic Ablation on Outcomes After SABR for Oligometastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
International Journal of Radiation Oncology, Biology, Physics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact of operability and total metastatic ablation on outcomes after stereotactic ablative radiotherapy (SABR) for oligometastases
Int. J. Radiat. Oncol. Biol. Phys 2022 Jun 22;[EPub Ahead of Print], S Siva, G Jones, M Bressel, M Shaw, S Chander, J Chu, N Plumridge, K Byrne, G Kothari, N Hardcastle, M Gaudreault, T Kron, G Wheeler, M MacManus, GG Hanna, DL Ball, S DavidFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.